Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and dosing regimens using ibudilast and a second agent for cancer therapy

Methods and dosing regimens using ibudilast and a second agent for cancer therapy

US Patent 11446283 · Granted Sep 20, 2022

Estimated economic value: $1,621,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods to decrease triglyceride synthesis in the liver2025
Methods of reducing plasma level of macrophage migratory inhibitory factor in pa2025
Methods of treating post-COVID condition(s)2024
Methods of minimizing cancer metastasis2024
Methods of preventing cancer metastasis2024
Treatment of progressive neurodegenerative disease with ibudilast2024
Methods of treating chemical gas exposure2024
Ibudilast oral formulations and methods of using same2024
Combination of ibudilast and riluzole and methods of using same2022
Methods of treating ophthalmic disease/disorder or injury with ibudilast2021
Treatment of progressive neurodegenerative disease with ibudilast2021
Combination of ibudilast and interferon-beta and methods of using same2021